149th ENMC International Workshop and 1st TREAT-NMD Workshop on: "planning phase i/ii clinical trials using systemically delivered antisense oligonucleotides in duchenne muscular dystrophy"

Neuromuscul Disord. 2008 Mar;18(3):268-75. doi: 10.1016/j.nmd.2007.11.010. Epub 2008 Jan 22.
No abstract available

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials, Phase I as Topic*
  • Clinical Trials, Phase II as Topic*
  • Genetic Therapy*
  • Humans
  • Muscular Dystrophy, Duchenne / genetics
  • Muscular Dystrophy, Duchenne / therapy*
  • Oligonucleotides, Antisense / therapeutic use*

Substances

  • Oligonucleotides, Antisense